ATF6 and infection: Although both VACV-WR and MVA are able to induce ATF6α activity, the kinetics and maximum levels of activation are different, suggesting that activation of the UPR-ATF6α branch at early/intermediate stages of viruses’ infection may be driven by WR-encoded genes that are possibly defective or absent in the MVA genome [9].